No description available.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24517号 / 医博第4959号 / 新制||医||1065(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 妹尾 浩, 教授 松田 道行, 教授 小濱 和貴 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Bovine mastitis is a common disease among dairy cattle characterized by the inflammation of the udders and loss of milk production. Mastitis-associated Escherichia coli (MAEC) are frequent causes of the disease, but the features that distinguish them from other E. coli strains remain enigmatic. MAEC infections can range from sub-clinical to severe, acute cases that can be fatal. Historically, the severity of mastitis has been attributed to host factors but more recently, a few bacterial genes have been shown to contribute to virulence in mastitis infections. In a large-scale genomic analysis of >100 MAEC isolates the gene for Chitinase A (ChiA) was positively associated with robust growth in the mammary glands during a mouse model of mastitis. This correlation suggests the hypothesis that ChiA contributes directly to MAEC fitness. The regulation of chiA has not been documented in contexts relevant to bovine mastitis. In the lab strain K-12, chiA is not expressed during aerobic growth in rich media. However, previous work with enterotoxigenic E. coli strain H10407 indicated that expression may be induced by hypoxic environments and the presence of bile salts. To measure expression of chiA, I created a chiA-GFP reporter plasmid and measured changes in fluorescence using flow cytometry. My results indicate promoter activity of chiA in MAEC is significantly increased in hypoxic conditions and the presence of bile salts, but not both. Adhesion to host tissues is an important characteristic of successful pathogens. Since ChiA facilitates adhesion between adherent-invasive E. coli and intestinal epithelial cells, I investigated its role in adhesion to bovine mammary epithelial cells in four MAEC strain backgrounds. Isogenic mutants lacking chiA were made in 2 mild (M45 and M93) and 2 severe (M111 and G1) clinical isolates. Loss of chiA resulted in significant reduction of adherence of M45, M93, and G1 to epithelial cells, but not M111. Wild type levels of adhesion were restored upon reintroduction of chiA into mutants through a plasmid vector. Additionally, the genomes of each MAEC isolate were analyzed for the presence of genes that could possibly influence the adhesion and virulence. Strain M111 contained genes for 2 distinct fimbriae that were not present in the other MAEC strains, possibly reducing its reliance on ChiA. The interaction of ChiA with mammary epithelial cells in MAEC could possibly offer an advantage for certain strains to be better suited to colonize and persist in mammary glands. Increased understanding of the regulation of chiA and its role in adherence can lead to novel targets for more effective treatment and prevention of bovine mastitis.

No description available.

No description available.

As EPEC típicas apresentam padrão de adesão localizada (LA) em células epiteliais, formando de microcolônias compactas. As EPEC atípicas aderem no padrão de adesão localizada-like (LAL), no qual não se observa microcolônias e que ocorre tardiamente em relação à LA. O objetivo deste estudo foi caracterizar a interação de EPEC atípica que apresenta o padrão LAL com a célula epitelial. A cinética da formação da lesão A/E, característica da patogênese de EPEC, demonstrou um atraso na adesão e na formação da lesão em EPEC atípica, que correspondeu à expressão tardia de Intimina, Tir e EspA. A complementação de EPEC atípica com o regulador perABC antecipou a expressão destes fatores e a formação da lesão A/E. Não foi observada relação entre outras adesinas descritas em DEC com o padrão LAL, bem como a mobilização dos receptores eucarióticos nucleolina e <font face=\"symbol\">b1-Integrina para o foco de adesão. Observou-se a possível interação da Intimina com um peptídeo da membrana da célula epitelial de 300 kDa, podendo tratar-se de um provável receptor para essa adesina. / Typical EPEC exhibit a localized adherence (LA) pattern in epithelial cells, where tight bacterial clusters are produced. Atypical EPEC produce a localized-like (LAL) adhesion pattern, in which the compact clusters are not formed and that occurs in a later stage of the infection. The aim of this study was to characterize the interaction of LAL-adherent atypical EPEC with the epithelial cell. The kinetics of the A/E lesion, the main feature of EPEC pathology, showed a clear delay in its formation by the atypical strains, probably a consequence of the delay observed in the expression of Intimin, Tir and EspA. The complementation of atypical EPEC with the perABC regulator revealed to be effective in not only advancing the expression of these factors, as well the formation of A/E lesion. No correlation was found between the presence of different adhesins already described in DEC and the LAL pattern. The analysis of the possible interaction of Intimin with epithelial cell receptors showed the presence of a 300 kDa peptide that it seems to interact with this adhesin.

As EPEC típicas apresentam padrão de adesão localizada (LA) em células epiteliais, formando de microcolônias compactas. As EPEC atípicas aderem no padrão de adesão localizada-like (LAL), no qual não se observa microcolônias e que ocorre tardiamente em relação à LA. O objetivo deste estudo foi caracterizar a interação de EPEC atípica que apresenta o padrão LAL com a célula epitelial. A cinética da formação da lesão A/E, característica da patogênese de EPEC, demonstrou um atraso na adesão e na formação da lesão em EPEC atípica, que correspondeu à expressão tardia de Intimina, Tir e EspA. A complementação de EPEC atípica com o regulador perABC antecipou a expressão destes fatores e a formação da lesão A/E. Não foi observada relação entre outras adesinas descritas em DEC com o padrão LAL, bem como a mobilização dos receptores eucarióticos nucleolina e <font face=\"symbol\">b1-Integrina para o foco de adesão. Observou-se a possível interação da Intimina com um peptídeo da membrana da célula epitelial de 300 kDa, podendo tratar-se de um provável receptor para essa adesina. / Typical EPEC exhibit a localized adherence (LA) pattern in epithelial cells, where tight bacterial clusters are produced. Atypical EPEC produce a localized-like (LAL) adhesion pattern, in which the compact clusters are not formed and that occurs in a later stage of the infection. The aim of this study was to characterize the interaction of LAL-adherent atypical EPEC with the epithelial cell. The kinetics of the A/E lesion, the main feature of EPEC pathology, showed a clear delay in its formation by the atypical strains, probably a consequence of the delay observed in the expression of Intimin, Tir and EspA. The complementation of atypical EPEC with the perABC regulator revealed to be effective in not only advancing the expression of these factors, as well the formation of A/E lesion. No correlation was found between the presence of different adhesins already described in DEC and the LAL pattern. The analysis of the possible interaction of Intimin with epithelial cell receptors showed the presence of a 300 kDa peptide that it seems to interact with this adhesin.

In polarized epithelial cells, vectorial protein trafficking is important for transporting specific membrane proteins to generate distinct apical and basolateral membrane protein compositions. The Exocyst is a conserved hetero-octameric protein complex, which regulates different aspects of protein trafficking, including tethering of the Golgi-derived vesicles to target membranes. Two of the Exocyst subunits, Sec5 and Exo84, competitively bind to the small GTPases, RalA and RalB, in a GTP-dependent manner. Although Ral GTPases have been proposed to mediate assembly of Exocyst holocomplexes, we hypothesize that they actually serve to allosterically regulate Exocyst functions by promoting association or disassociation of additional factors. Previous studies have shown that active RalA, but not RalB, accelerated basolateral exocytosis of E-cadherin. In contrast, knockdown of RalB, but not RalA, disrupts endocytosis of E-cadherin. However, mechanisms by which association of Ral GTPases with Sec5 and Exo84 regulate basolateral protein trafficking remain unclear. Here we investigate roles of Ral GTPases and the Exocyst in regulating basolateral protein trafficking using Madin Darby canine kidney (MDCK) cells and RNA interference (RNAi) technology. We show that RalA, but not RalB, is required for basolateral exocytosis of vesicular stomatitis virus glycoprotein (VSV-G) in the MDCK cells. We combined immunofluorescent labeling and surface biotinylation assays to demonstrate that RalA regulates VSV-G trafficking through the distinct interactions with Sec5 and Exo84. We also show that a Ral-uncoupled Sec5 mutant, but not a Ral-uncoupled Exo84 mutant, inhibits E-cadherin exocytosis. These results suggested that RalA and the Exocyst are required for basolateral exocytosis, and that RalA-Sec5 and RalA-Exo84 interactions play different roles during this process. Our study may provide new insights into mechanisms regulating protein trafficking in epithelial cells, and potentially lead to development of new therapeutic targets for the treatment of diseases in which exocytosis is impaired, such as Polycystic kidney disease and diabetes.

The genotoxicity of energetic compounds (i.e., explosives) that are known to be present in contaminated soils at military training sites has not been extensively investigated. Thus, the Salmonella mutagenicity and Muta(TM)Mouse assays were employed as in vitro assays to examine the mutagenic activity of twelve explosive compounds, as well as three soil samples from Canadian Forces Base Petawawa. Salmonella analyses employed strains TA98 (frameshift mutations) and TA100 (base-pair substitution mutations), as well as the metabolically-enhanced YG1041 (TA98 background) and YG1042 (TA100 background), with and without exogenous metabolic activation (S9). For Salmonella analyses, the results indicate that ten of the explosive compounds were mutagenic, and consistently elicited direct-acting, base-pair substitution activity. All three soil samples were also observed to be mutagenic, eliciting direct-acting, frameshift activity. Mutagenic potencies were significantly higher on the metabolically-enhanced strains for all compounds and soil samples. For Muta(TM)Mouse analyses on FE1 cells, the results indicate that the majority of explosive compounds did not exhibit mutagenic activity. All three soil samples elicited significant positive responses (PET 1 and PET 3 without S9, and PET 2 with S9), and although there is some evidence of a concentration-related trend, the responses were weak. Correspondence of the mutagenic activity observed with the two assay systems, for both the explosive compounds and soil samples, was negligible. The differential response is likely due to differences in metabolic capacity between the two assay systems. Furthermore, it is likely that there are unidentified compounds present in these soil samples that are, at least in part, responsible for the observed mutagenic activity. Additional testing of other explosive compounds, as well as soil samples from other military training sites, using a variety of in vitro and in vivo assays, is warranted in order to reliably estimate mutagenic hazard and subsequently assess risk to human health.

The genotoxicity of energetic compounds (i.e., explosives) that are known to be present in contaminated soils at military training sites has not been extensively investigated. Thus, the Salmonella mutagenicity and Muta(TM)Mouse assays were employed as in vitro assays to examine the mutagenic activity of twelve explosive compounds, as well as three soil samples from Canadian Forces Base Petawawa. Salmonella analyses employed strains TA98 (frameshift mutations) and TA100 (base-pair substitution mutations), as well as the metabolically-enhanced YG1041 (TA98 background) and YG1042 (TA100 background), with and without exogenous metabolic activation (S9). For Salmonella analyses, the results indicate that ten of the explosive compounds were mutagenic, and consistently elicited direct-acting, base-pair substitution activity. All three soil samples were also observed to be mutagenic, eliciting direct-acting, frameshift activity. Mutagenic potencies were significantly higher on the metabolically-enhanced strains for all compounds and soil samples. For Muta(TM)Mouse analyses on FE1 cells, the results indicate that the majority of explosive compounds did not exhibit mutagenic activity. All three soil samples elicited significant positive responses (PET 1 and PET 3 without S9, and PET 2 with S9), and although there is some evidence of a concentration-related trend, the responses were weak. Correspondence of the mutagenic activity observed with the two assay systems, for both the explosive compounds and soil samples, was negligible. The differential response is likely due to differences in metabolic capacity between the two assay systems. Furthermore, it is likely that there are unidentified compounds present in these soil samples that are, at least in part, responsible for the observed mutagenic activity. Additional testing of other explosive compounds, as well as soil samples from other military training sites, using a variety of in vitro and in vivo assays, is warranted in order to reliably estimate mutagenic hazard and subsequently assess risk to human health.